ARCHIVES

ODAC Discussion: NCI’s Richard Simon Cautions About Rules Of Thumb

This article is from The Cancer Letter archive.

Vol. 35 No. 04 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

Cell Therapeutics To Appeal FDA Decision on Pixantrone.

September 17, 2010

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

September 30, 2005

In Brief: ACCC Celebrates 25th: James Hospital Receives Large Donations

April 9, 1999

Advocates Call For Metrics And Action Plan In NCI’s Redesign of Cooperative Groups

July 8, 2011

Nancy Davidson Named Director Of UPCI, Succeeding Herberman.

November 21, 2008

In Brief: Broder Invokes Cancer Act Provision To Inform Hammer, Bush Of Potential Damage Of 32% Cut

September 7, 1990